TABLE 4.
The whole results of KEGG functional analysis.
| hsa04310 | Wnt signaling pathway | 0.030193 | 7 |
| hsa04260 | Cardiac muscle contraction | 0.191447 | 4 |
| hsa04972 | Pancreatic secretion | 0.191447 | 4 |
| hsa04974 | Protein digestion and absorption | 0.191447 | 4 |
| hsa04530 | Tight junction | 0.191447 | 5 |
| hsa05022 | Pathways of neurodegeneration - multiple diseases | 0.191447 | 9 |
| hsa00592 | alpha-Linolenic acid metabolism | 0.232448 | 2 |
| hsa05130 | Pathogenic Escherichia coli infection | 0.232448 | 5 |
| hsa00591 | Linoleic acid metabolism | 0.232448 | 2 |
| hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 0.232448 | 3 |
| hsa04024 | cAMP signaling pathway | 0.232448 | 5 |
| hsa05010 | Alzheimer’s disease | 0.232448 | 7 |
| hsa04514 | Cell adhesion molecules | 0.232448 | 4 |
| hsa04512 | ECM-receptor interaction | 0.232448 | 3 |
| hsa00350 | Tyrosine metabolism | 0.232448 | 2 |
| hsa05410 | Hypertrophic cardiomyopathy | 0.232448 | 3 |
| hsa04390 | Hippo signaling pathway | 0.232448 | 4 |
| hsa05414 | Dilated cardiomyopathy | 0.249298 | 3 |
| hsa00260 | Glycine, serine and threonine metabolism | 0.249298 | 2 |
| hsa04975 | Fat digestion and absorption | 0.264308 | 2 |
| hsa04080 | Neuroactive ligand-receptor interaction | 0.264308 | 6 |